Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) EBITDA Margin (2018 - 2025)

Exagen's EBITDA Margin history spans 8 years, with the latest figure at 29.91% for Q4 2025.

  • For Q4 2025, EBITDA Margin fell 514.0% year-over-year to 29.91%; the TTM value through Dec 2025 reached 21.13%, up 337.0%, while the annual FY2025 figure was 21.13%, 337.0% up from the prior year.
  • EBITDA Margin reached 29.91% in Q4 2025 per XGN's latest filing, down from 17.98% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 15.29% in Q2 2025 to a low of 184.91% in Q2 2022.
  • Average EBITDA Margin over 5 years is 50.37%, with a median of 37.59% recorded in 2023.
  • Peak YoY movement for EBITDA Margin: tumbled -13995bps in 2022, then skyrocketed 15014bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 49.29% in 2021, then plummeted by -129bps to 112.88% in 2022, then skyrocketed by 67bps to 37.39% in 2023, then soared by 34bps to 24.77% in 2024, then fell by -21bps to 29.91% in 2025.
  • Per Business Quant, the three most recent readings for XGN's EBITDA Margin are 29.91% (Q4 2025), 17.98% (Q3 2025), and 15.29% (Q2 2025).